WHO WE ARE
A Company As Unique As Your Fingerprint
Within the lines of a fingerprint is the roadmap that makes each one of us unique. At EXOKĒRYX, our roadmap to transforming early disease detection combines principles from the semiconductor industry with breakthrough biotechnology.
EVs (extracellular vescicles) are crucial to cellular communication within our bodies and can be a key factor in early detection.
EXOKĒRYX is revolutionizing early-stage disease and cancer diagnostics by combining the power of solid-state electronics with EV-based biomarker discovery.
We are developing a novel chip-based platform that leverages the dipole moments of EVs to isolate, and transistor technology to quantify and analyze them in biological fluids to create the CancerFingerprintTM.
From a few drops of biological fluid, we can identify biomarkers with greater sensitivity than standard methods. This level of sensitivity allows for the detection of cancer and other serious disease earlier than is possible with current technologies.
Meaning we can extend quality of life by avoiding therapy pathways that are as harmful as the disease itself.
It’s time to usher in the new next generation technology.
It’s time to put our fingerprint on positive patient outcomes.
